Acenocoumarol and Heparin Compared with Acenocoumarol Alone in the Initial Treatment of Proximal-Vein Thrombosis
- 19 November 1992
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 327 (21) , 1485-1489
- https://doi.org/10.1056/nejm199211193272103
Abstract
In most countries, heparin is used in the initial treatment of patients with deep-vein thrombosis. Well-designed studies establishing the efficacy of heparin therapy are lacking, however. Treatment with acenocoumarol alone, according to the hypothesis that high dosages of oral anticoagulants obviate the need for heparin, is considered an effective alternative in some countries.Keywords
This publication has 16 references indexed in Scilit:
- Heparin for 5 Days as Compared with 10 Days in the Initial Treatment of Proximal Venous ThrombosisNew England Journal of Medicine, 1990
- Equipoise and the Ethics of Clinical ResearchNew England Journal of Medicine, 1987
- SAFETY AND EFFICACY OF WARFARIN STARTED EARLY AFTER SUBMASSIVE VENOUS THROMBOSIS OR PULMONARY EMBOLISMThe Lancet, 1986
- Heparin and the In-Hospital Management of Deep Venous Thrombosis: Cost ConsiderationsMayo Clinic Proceedings, 1986
- Diagnostic Value of Ventilation-Perfusion Lung Scanning in Patients with Suspected Pulmonary EmbolismChest, 1985
- The diagnosis of acute, recurrent, deep-vein thrombosis: a diagnostic challenge.Circulation, 1983
- Thromboembolic Complications During Anticoagulant TherapyArchives of Surgery, 1972
- Roentgen Diagnosis of Venous Thrombosis in the LegArchives of Surgery, 1972
- Serum-Induced ThrombosisCirculation, 1959
- THROMBOSIS EARLY DIAGNOSIS AND ABORTIVE TREATMENT WITH HEPARINThe Lancet, 1946